APO Research
Talk to an analyst

APO RESEARCH · REPORT

Circulating Tumor Cell(CTC)Detection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Circulating Tumor Cell(CTC)Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

5 June 2026180 pages

Choose your research edition.

Industry ResearchCirculating Tumor Cell(CTC)Detection Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Circulating Tumor Cell(CTC)Detection Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Circulating Tumor Cell(CTC)Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Circulating Tumor Cell(CTC)Detection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Circulating Tumor Cell(CTC)Detection Market Analysis and Forecast 2026-2032235 pages · $4,950 USD

Market perspective

The global Circulating Tumor Cell(CTC)Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Circulating Tumor Cell(CTC)Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Circulating Tumor Cell(CTC)Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Circulating Tumor Cell(CTC)Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Circulating Tumor Cell(CTC)Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Circulating Tumor Cell(CTC)Detection include Rarecyte, ANGLE plc, Biocept Inc., Bio-Rad Laboratories Inc., Fluxion Biosciences Inc., F. Hoffmann-La Roche AG, Sysmex Europe SE and Qiagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Circulating Tumor Cell(CTC)Detection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Circulating Tumor Cell(CTC)Detection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Circulating Tumor Cell(CTC)Detection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Circulating Tumor Cell(CTC)Detection market size, projected growth trends, production technologies, key applications, and end-use industries.

Circulating Tumor Cell(CTC)Detection Segment by Company

Rarecyte

ANGLE plc

Biocept Inc.

Bio-Rad Laboratories Inc.

Fluxion Biosciences Inc.

F. Hoffmann-La Roche AG

Sysmex Europe SE

Qiagen

Circulating Tumor Cell(CTC)Detection Segment by Type

Epithelial Cell Phenotype

Mesenchymal Cell Phenotype

Mixed Epithelial-Mesenchymal Phenotype

Circulating Tumor Cell(CTC)Detection Segment by Application

Cancer Diagnosis

Tumor Dynamic Assessment

Tumor Recurrence Monitoring

Circulating Tumor Cell(CTC)Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Circulating Tumor Cell(CTC)Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Circulating Tumor Cell(CTC)Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Circulating Tumor Cell(CTC)Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Circulating Tumor Cell(CTC)Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Circulating Tumor Cell(CTC)Detection industry.

Chapter 3: Detailed analysis of Circulating Tumor Cell(CTC)Detection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circulating Tumor Cell(CTC)Detectionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Epithelial Cell Phenotype Table 3. Key Players of Mesenchymal Cell Phenotype Table 4. Key Players of Mixed Epithelial-Mesenchymal Phenotype Table 4. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Diagnosis Table 6. Key Players of Tumor Dynamic Assessment Table 7. Key Players of Tumor Recurrence Monitoring Table 8. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2021-2026) Table 11. Global Circulating Tumor Cell(CTC)Detection Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Circulating Tumor Cell(CTC)Detection Market Share by Region (2027-2032) Table 13. Circulating Tumor Cell(CTC)Detection Industry Trends Table 14. Circulating Tumor Cell(CTC)Detection Industry Drivers Table 15. Circulating Tumor Cell(CTC)Detection Industry Opportunities and Challenges Table 16. Circulating Tumor Cell(CTC)Detection Industry Restraints Table 17. Global Circulating Tumor Cell(CTC)Detection Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Company (2021-2026) Table 19. Global Circulating Tumor Cell(CTC)Detection Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Circulating Tumor Cell(CTC)Detection Key Company Head Office and Area Served Table 21. Global Circulating Tumor Cell(CTC)Detection Company, Product Type & Application Table 22. Global Circulating Tumor Cell(CTC)Detection Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Circulating Tumor Cell(CTC)Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Circulating Tumor Cell(CTC)Detection Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2021-2026) Table 29. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2027-2032) Table 30. Global Circulating Tumor Cell(CTC)Detection Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2021-2026) Table 34. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2027-2032) Table 35. Rarecyte Company Information Table 36. Rarecyte Business Overview Table 37. Rarecyte Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Rarecyte Circulating Tumor Cell(CTC)Detection Product Portfolio Table 39. Rarecyte Recent Development Table 40. ANGLE plc Company Information Table 41. ANGLE plc Business Overview Table 42. ANGLE plc Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. ANGLE plc Circulating Tumor Cell(CTC)Detection Product Portfolio Table 44. ANGLE plc Recent Development Table 45. Biocept Inc. Company Information Table 46. Biocept Inc. Business Overview Table 47. Biocept Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Biocept Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio Table 49. Biocept Inc. Recent Development Table 50. Bio-Rad Laboratories Inc. Company Information Table 51. Bio-Rad Laboratories Inc. Business Overview Table 52. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio Table 54. Bio-Rad Laboratories Inc. Recent Development Table 55. Fluxion Biosciences Inc. Company Information Table 56. Fluxion Biosciences Inc. Business Overview Table 57. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio Table 59. Fluxion Biosciences Inc. Recent Development Table 60. F. Hoffmann-La Roche AG Company Information Table 61. F. Hoffmann-La Roche AG Business Overview Table 62. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product Portfolio Table 64. F. Hoffmann-La Roche AG Recent Development Table 65. Sysmex Europe SE Company Information Table 66. Sysmex Europe SE Business Overview Table 67. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product Portfolio Table 69. Sysmex Europe SE Recent Development Table 70. Qiagen Company Information Table 71. Qiagen Business Overview Table 72. Qiagen Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Qiagen Circulating Tumor Cell(CTC)Detection Product Portfolio Table 74. Qiagen Recent Development Table 75. North America Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026) Table 81. North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032) Table 82. Europe Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026) Table 88. Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032) Table 89. China Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 90. China Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 91. China Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 92. China Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026) Table 99. Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Circulating Tumor Cell(CTC)Detection Product Image Figure 2. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Circulating Tumor Cell(CTC)Detection Market Share by Type: 2025 VS 2032 Figure 4. Epithelial Cell Phenotype Image Figure 5. Mesenchymal Cell Phenotype Image Figure 6. Mixed Epithelial-Mesenchymal Phenotype Image Figure 7. Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Circulating Tumor Cell(CTC)Detection Market Share by Application: 2025 VS 2032 Figure 9. Cancer Diagnosis Image Figure 10. Tumor Dynamic Assessment Image Figure 11. Tumor Recurrence Monitoring Image Figure 12. Global Circulating Tumor Cell(CTC)Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 14. Global Circulating Tumor Cell(CTC)Detection Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Circulating Tumor Cell(CTC)Detection Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Circulating Tumor Cell(CTC)Detection Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Type (2021-2032) Figure 21. Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Circulating Tumor Cell(CTC)Detection Revenue Market Share by Application (2021-2032) Figure 23. North America Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 24. North America Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032) Figure 25. North America Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032) Figure 26. North America Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032) Figure 27. United States Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 28. Canada Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 30. Europe Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 31. Europe Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032) Figure 32. Europe Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032) Figure 33. Europe Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032) Figure 34. Germany Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 35. France Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 37. Italy Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 38. Russia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 40. China Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 41. China Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032) Figure 42. China Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032) Figure 43. Asia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 44. Asia Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032) Figure 45. Asia Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032) Figure 46. Asia Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032) Figure 47. Japan Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 51. India Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 52. Australia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032) Figure 57. Brazil Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 62. UAE Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 64. Chile Circulating Tumor Cell(CTC)Detection Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Epithelial Cell Phenotype
  • Mesenchymal Cell Phenotype
  • Mixed Epithelial-Mesenchymal Phenotype
Applications
  • Cancer Diagnosis
  • Tumor Dynamic Assessment
  • Tumor Recurrence Monitoring
Companies covered
  • Rarecyte
  • ANGLE plc
  • Biocept Inc.
  • Bio-Rad Laboratories Inc.
  • Fluxion Biosciences Inc.
  • F. Hoffmann-La Roche AG
  • Sysmex Europe SE
  • Qiagen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Epithelial Cell Phenotype
  5. 1.2.3 Mesenchymal Cell Phenotype
  6. 1.2.4 Mixed Epithelial-Mesenchymal Phenotype
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Circulating Tumor Cell(CTC)Detection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer Diagnosis
  10. 1.3.3 Tumor Dynamic Assessment
  11. 1.3.4 Tumor Recurrence Monitoring
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Circulating Tumor Cell(CTC)Detection Growth Trends by Region
  14. 1.5.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Circulating Tumor Cell(CTC)Detection Market Size by Region (2021-2026)
  16. 1.5.3 Circulating Tumor Cell(CTC)Detection Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Circulating Tumor Cell(CTC)Detection Market Dynamics
  1. 2.1 Circulating Tumor Cell(CTC)Detection Industry Trends
  2. 2.2 Circulating Tumor Cell(CTC)Detection Industry Drivers
  3. 2.3 Circulating Tumor Cell(CTC)Detection Industry Opportunities and Challenges
  4. 2.4 Circulating Tumor Cell(CTC)Detection Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Circulating Tumor Cell(CTC)Detection Revenue by Company (2021-2026)
  2. 3.2 Global Circulating Tumor Cell(CTC)Detection Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Circulating Tumor Cell(CTC)Detection Key Company Head office and Area Served
  4. 3.4 Global Circulating Tumor Cell(CTC)Detection Company, Product Type & Application
  5. 3.5 Global Circulating Tumor Cell(CTC)Detection Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Circulating Tumor Cell(CTC)Detection Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Circulating Tumor Cell(CTC)Detection Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Circulating Tumor Cell(CTC)Detection Tier 1, Tier 2, and Tier 3
4 Circulating Tumor Cell(CTC)Detection Market by Type
  1. 4.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2032)
  3. 4.3 Global Circulating Tumor Cell(CTC)Detection Market Size Share by Type (2021-2032)
5 Circulating Tumor Cell(CTC)Detection Market by Application
  1. 5.1 Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2032)
  3. 5.3 Global Circulating Tumor Cell(CTC)Detection Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Rarecyte
  2. 6.1.1 Rarecyte Company Information
  3. 6.1.2 Rarecyte Business Overview
  4. 6.1.3 Rarecyte Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Rarecyte Circulating Tumor Cell(CTC)Detection Product Portfolio
  6. 6.1.5 Rarecyte Recent Developments
  7. 6.2 ANGLE plc
  8. 6.2.1 ANGLE plc Company Information
  9. 6.2.2 ANGLE plc Business Overview
  10. 6.2.3 ANGLE plc Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 ANGLE plc Circulating Tumor Cell(CTC)Detection Product Portfolio
  12. 6.2.5 ANGLE plc Recent Developments
  13. 6.3 Biocept Inc.
  14. 6.3.1 Biocept Inc. Company Information
  15. 6.3.2 Biocept Inc. Business Overview
  16. 6.3.3 Biocept Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Biocept Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio
  18. 6.3.5 Biocept Inc. Recent Developments
  19. 6.4 Bio-Rad Laboratories Inc.
  20. 6.4.1 Bio-Rad Laboratories Inc. Company Information
  21. 6.4.2 Bio-Rad Laboratories Inc. Business Overview
  22. 6.4.3 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bio-Rad Laboratories Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio
  24. 6.4.5 Bio-Rad Laboratories Inc. Recent Developments
  25. 6.5 Fluxion Biosciences Inc.
  26. 6.5.1 Fluxion Biosciences Inc. Company Information
  27. 6.5.2 Fluxion Biosciences Inc. Business Overview
  28. 6.5.3 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fluxion Biosciences Inc. Circulating Tumor Cell(CTC)Detection Product Portfolio
  30. 6.5.5 Fluxion Biosciences Inc. Recent Developments
  31. 6.6 F. Hoffmann-La Roche AG
  32. 6.6.1 F. Hoffmann-La Roche AG Company Information
  33. 6.6.2 F. Hoffmann-La Roche AG Business Overview
  34. 6.6.3 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche AG Circulating Tumor Cell(CTC)Detection Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche AG Recent Developments
  37. 6.7 Sysmex Europe SE
  38. 6.7.1 Sysmex Europe SE Company Information
  39. 6.7.2 Sysmex Europe SE Business Overview
  40. 6.7.3 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Sysmex Europe SE Circulating Tumor Cell(CTC)Detection Product Portfolio
  42. 6.7.5 Sysmex Europe SE Recent Developments
  43. 6.8 Qiagen
  44. 6.8.1 Qiagen Company Information
  45. 6.8.2 Qiagen Business Overview
  46. 6.8.3 Qiagen Circulating Tumor Cell(CTC)Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Qiagen Circulating Tumor Cell(CTC)Detection Product Portfolio
  48. 6.8.5 Qiagen Recent Developments
7 North America
  1. 7.1 North America Circulating Tumor Cell(CTC)Detection Market Size (2021-2032)
  2. 7.2 North America Circulating Tumor Cell(CTC)Detection Market Size by Type
  3. 7.2.1 North America Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026)
  4. 7.2.2 North America Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032)
  5. 7.2.3 North America Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032)
  6. 7.3 North America Circulating Tumor Cell(CTC)Detection Market Size by Application
  7. 7.3.1 North America Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026)
  8. 7.3.2 North America Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032)
  9. 7.3.3 North America Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032)
  10. 7.4 North America Circulating Tumor Cell(CTC)Detection Market Size by Country
  11. 7.4.1 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026)
  13. 7.4.3 North America Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032)
  14. 7.4.4 North America Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Circulating Tumor Cell(CTC)Detection Market Size (2021-2032)
  2. 8.2 Europe Circulating Tumor Cell(CTC)Detection Market Size by Type
  3. 8.2.1 Europe Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026)
  4. 8.2.2 Europe Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032)
  5. 8.2.3 Europe Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032)
  6. 8.3 Europe Circulating Tumor Cell(CTC)Detection Market Size by Application
  7. 8.3.1 Europe Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026)
  8. 8.3.2 Europe Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032)
  9. 8.3.3 Europe Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032)
  10. 8.4 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country
  11. 8.4.1 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026)
  13. 8.4.3 Europe Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032)
  14. 8.4.4 Europe Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Circulating Tumor Cell(CTC)Detection Market Size (2021-2032)
  2. 9.2 China Circulating Tumor Cell(CTC)Detection Market Size by Type
  3. 9.2.1 China Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026)
  4. 9.2.2 China Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032)
  5. 9.2.3 China Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032)
  6. 9.3 China Circulating Tumor Cell(CTC)Detection Market Size by Application
  7. 9.3.1 China Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026)
  8. 9.3.2 China Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032)
  9. 9.3.3 China Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Circulating Tumor Cell(CTC)Detection Market Size (2021-2032)
  2. 10.2 Asia Circulating Tumor Cell(CTC)Detection Market Size by Type
  3. 10.2.1 Asia Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026)
  4. 10.2.2 Asia Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032)
  5. 10.2.3 Asia Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032)
  6. 10.3 Asia Circulating Tumor Cell(CTC)Detection Market Size by Application
  7. 10.3.1 Asia Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026)
  8. 10.3.2 Asia Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032)
  9. 10.3.3 Asia Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032)
  10. 10.4 Asia Circulating Tumor Cell(CTC)Detection Market Size by Country
  11. 10.4.1 Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026)
  13. 10.4.3 Asia Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032)
  14. 10.4.4 Asia Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Circulating Tumor Cell(CTC)Detection Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst